Pitadus Tablets 4 mg (Pitavastatin Calcium)

Adult dose

For adults, the usual starting dose is 1 to 2 milligrams of Pitavastatin Calcium taken once daily. If the LDL-cholesterol lowering effect is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose appropriately at intervals of 4 weeks or more based on LDL-cholesterol levels, treatment goals, and patient responses.

This medication should not be used in certain patients. For example, patients with an allergy to any component of this drug, patients with active liver disease, patients with severe liver impairment or bile duct obstruction, and patients taking cyclosporine should not take this medication. Additionally, it should not be administered to patients with myopathies, pregnant women, women who might become pregnant, nursing mothers, and children. Patients with genetic issues like lactose intolerance should also avoid this medication. This medication should be administered with caution in patients with impaired kidney function or a history of liver disease, and in those who consume alcohol excessively. In particular, caution is required when taken in combination with fibrates or niacin due to the increased risk of muscle damage. Elderly individuals, patients with hypothyroidism, and those with a history of muscular disease should also be cautious. During the use of this medication, symptoms such as muscle pain, weakness, abdominal pain, rash, and itching may appear; if any abnormal symptoms occur, immediate notification of medical personnel is required. Regular liver function tests and blood tests should be conducted, and if there are signs of liver dysfunction, thrombocytopenia, or muscle damage, discontinuation of therapy is necessary. This medication may interact with other drugs, so caution is needed when used with cyclosporine, fibrates, niacin, and cholestyramine. Always consult medical personnel regarding other medications being taken. Elderly patients have decreased bodily functions and may experience adverse reactions more easily, so caution is needed during administration. Pregnant or nursing women should not take this medication, and women who could become pregnant should confirm their pregnancy status before taking it. The safety of this medication in children has not been established, therefore it is not used. This medication must be taken exactly as prescribed, and tablets should be swallowed whole without being divided. When storing, keep it out of the reach of children, and store it in its original container to maintain its quality. This medication can rarely cause serious muscle diseases; if muscle-related symptoms appear, immediate discontinuation and consultation with medical personnel are necessary.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, peeling skin, pain in oral/ocular mucosa, severe cutaneous adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, respiratory issues, yellowing of the skin or eyes, jaundice, extreme drowsiness, liver anomalies, sudden and severe headache

Mild side effects

• Abdominal pain
• rash
• fatigue
• numbness
• itching
• stiffness
• drowsiness
• insomnia
• headache
• dizziness

This medication is sensitive to light and should be stored in a light-resistant container at room temperature between 1 and 30 degrees Celsius.

Appearance

Pale yellow round film-coated tablet

Package unit

30 tablets (10 tablets/PTP packaging X 3), 100 tablets/bottle